ID   CSLEX1
AC   CVCL_JZ51
SY   CSLEX-1; CSLEX 1
DR   Wikidata; Q54814664
RX   Patent=US4752569;
RX   PubMed=6386148;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8580.
CC   Monoclonal antibody isotype: IgM.
CC   Monoclonal antibody target: ChEBI; CHEBI_61711; Alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc (Sialyl Lewis X; CD15; SSEA-1).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 27-11-25; Version: 6
//
RX   Patent=US4752569;
RA   Terasaki, Paul Ichiro
RA   Hirota, Masaki
RA   Fukushima, Kiyoyasu
RA   Wakisaka, Akemi
RA   Iguro, Takashi
RT   "Sialylated LewisX epitope, antibodies and diagnosis.";
RL   Patent number US4752569, 21-Jun-1988.
//
RX   PubMed=6386148;
RA   Fukushima, Kiyoyasu
RA   Hirota, Masaki
RA   Terasaki, Paul Ichiro
RA   Wakisaka, Akemi
RA   Togashi, Hiroyuki
RA   Chia, David
RA   Suyama, Naofumi
RA   Fukushi, Yasuo
RA   Nudelman, Edward Donald
RA   Hakomori, Sen-itiroh
RT   "Characterization of sialosylated LewisX as a new tumor-associated
RT   antigen.";
RL   Cancer Res. 44:5279-5285(1984).
//